Clinical trial
Patients Diagnosed With Advanced Malignancy or Myelodysplasia, Tested by Standardized Sequencing, and Treated by Physician-Determined Care Plan: A CureOne Observational Registry (N1)
NCT02900248 is registered in ClinicalTrials.gov with CureOne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patients Diagnosed With Advanced Malignancy or Myelodysplasia, Tested by Standardized Sequencing, and Treated by Physician-Determined Care Plan: A CureOne Observational Registry (N1)
- Lead sponsor
- CureOne
- Phase
- Observational
- Overall status
- Terminated
- Start date
- October 2, 2017
- Completion date
- March 29, 2019
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anal neoplasms, biliary tract neoplasms, bladder neoplasms, brain neoplasms, breast neoplasms, colon neoplasms, endometrial neoplasms, gastric neoplasms, head and neck neoplasms, hematologic neoplasms, kidney neoplasms, liver neoplasms, lung neoplasms, melanoma, multiple myeloma, myelodysplastic syndromes, neoplasms, ovarian neoplasms, pancreatic neoplasms, prostate neoplasms, rectal neoplasms, sarcoma, skin neoplasms, testicular neoplasms, uterine cervical neoplasms